PubMed Health⌕ Search

Biomedical subjects

H Szarmach

Publications and source records attributed to H Szarmach.

At least 19 recordsLinked to original sources
PubMed1992

[The effect of occupational environment on the development of skin lesions in workers at a tableware porcelain plant].

This work reports on the skin diseases which occur among the workers of the ceramic industry. The most frequently observed diseases were: dermatomycosis, eczema as a result of wear, and allergic diseases. Nickel, and also cobalt, turpentine, paraphenyldiamine and detergents were the main allergens. Mycotic infection was observed primarily among the workers using common bathrooms.

Adult↗
PubMed1989

[Labial flaps in reconstruction of lower lip].

The authors present the evolution of the lower lip reconstruction by labial flaps. Some details of the operation technique and the range of indications for this type of plastic operation have been discussed.

Humans↗
PubMed1988

Epidemiology of nickel allergy: results of a follow-up analysis of patients with positive patch tests to nickel.

In a previous paper, we reported on nickel sensitivity in 2400 consecutive patients in 5 countries. 3 years later, we reassessed 104 of the 157 nickel-positive patients of this former study and found 13 now to be negative to nickel sulphate. Nearly all the others can no longer tolerate nickel contact. 68 patients were free from nickel dermatitis, 16 showed a very mild eczema or dyshidrosis, and 13 were suffering from chronic hand dermatitis. 42 of 104 patients had changed their occupation, 36 successfully, with clearance of skin lesions. Rehabilitation by avoidance of nickel-containing costume jewelry, wrist-watches and clothing buckles, and by change of occupation, is possible and necessary.

Dermatitis, Contact↗
PubMed1986

[Mixed infections of the urogenital tract with Trichomonas vaginalis and yeast-like fungi in humans with reference to treatment].

Comparative studies on the incidence of mixed infections with T. vaginalis and yeast-like fungi in man carried out within the years 1969-1980 and 1981-1984 showed a progressive increase of this kind of disease. Clinical treatment with Clotrimazole was performed in 35 patients. Local therapy with Clotrimazole was effective, if 3-5 days later the patients receive Tinidazole at one dosage. In some patients, the therapy has to be continued with Metronidazole.

Administration, Oral↗
PubMed1986

Ciprofloxacin in acute male gonorrhea.

100 male adults suffering from acute gonococcal urethritis were hospitalised and treated with decreasing doses from 2000 mg to 100 mg of ciprofloxacin (1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline carboxylic acid, Bay o 9867; designated tradename: Ciprobay). Clinical signs (burning, exudate, edema, inflammation) and bacteriology (native and culture) were assessed hourly during the first 9 h and at 12, 24 and 72 h after start of therapy. Most patients were controlled during 10 days. 99 patients showed clinical and bacteriological cure. One patient with subacute gonococcal urethritis (protocol violation) did not react on 250 mg. No postgonococcal urethritis was seen. No side effects were reported. For the acute male gonococcal urethritis a 100 mg single dose treatment with ciprofloxacin can be recommended.

Acute Disease↗
PubMed1985

[Trichomoniasis of the urogenital tract in patients hospitalized in 1976-1983].

We report on investigations carried out on T. vaginalis and mixed infection (T. vaginalis and yeast-like fungi). Special attention was paid to metronidazol resistance on T. vaginalis strains isolated from patients who had been repeatedly treated with this medicament. Therefore we point to the necessity of defining the patients' susceptibility to this remedy.

Adolescent↗
PubMed1977

[Clotrimazol therapy of skin mycoses].

Clinical evaluation of a 1% clotrimazole cream and solution on 236 in and out patients with different clinical manifestations of mycotic infections was done. Clotrimazole, both cream and solution, is an effective and well tolerated agent in the treatment of infections due to dermatophytes and yeasts. Best results were recorded with patients suffering from pityriasis versicolor and erythrasma, and interdigital erosion.

Administration, Topical↗